Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 1626 (LINC01626)
- Target
- LINC01626
- Molecular classification
- Long non-coding RNA (lncRNA), Long intergenic non-coding RNA (lincRNA)
01
Overview
LINC01626 (Long intergenic non-protein coding RNA 1626) is a member of the long non-coding RNA (lncRNA) gene family, specifically classified as a long intergenic non-protein coding RNA (lincRNA)[1]. These are RNA molecules greater than 200 nucleotides in length that do not encode proteins but have regulatory roles in gene expression, chromatin organization, and other cellular processes[3]. As of now, there is no published evidence linking LINC01626 to any specific diseases, biological functions, or drug interactions. The gene is annotated in standard genomic databases but lacks experimental characterization or status as a therapeutic target[1][3].
- Other names
- LINC01626LOC105377853
02
Mechanism of action
Not applicable; no known drugs target LINC01626
03
Biological functions
There is no experimentally validated biological function for LINC01626, but lincRNAs in general participate in gene regulation and chromatin remodeling
04
Disease associations
None specifically described for LINC01626. Some other lincRNAs are implicated in cancer and other diseases, but no such association is documented for LINC01626
05
Safety considerations
None identified; as no drugs target LINC01626 and its biological function is not established, there are no known safety concerns
06
Interacting drugs
None reported
07
Biomarkers
None; LINC01626 is not a recognized biomarker for patient selection or efficacy monitoring
Beyond the preview
Go deeper on Long intergenic non-protein coding RNA 1626 (LINC01626).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Long intergenic non-protein coding RNA 1626 (LINC01626).